Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features.
Mathieu R, Pignot G, Ingles A, Crepel M, Bigot P, Bernhard JC, Joly F, Guy L, Ravaud A, Azzouzi AR, Gravis G, Chevreau C, Zini L, Lang H, Pfister C, Lechevallier E, Fais PO, Berger J, Vayleux B, Roupret M, Audenet F, Descazeaud A, Rigaud J, Machiels JP, Staehler M, Salomon L, Ferriere JM, Kleinclauss F, Bensalah K, Patard JJ. Mathieu R, et al. Among authors: lechevallier e. Urol Oncol. 2015 Aug;33(8):339.e9-15. doi: 10.1016/j.urolonc.2015.05.014. Epub 2015 Jun 16. Urol Oncol. 2015. PMID: 26087971
Prognostic value of nuclear grade of renal cell carcinoma.
Bretheau D, Lechevallier E, de Fromont M, Sault MC, Rampal M, Coulange C. Bretheau D, et al. Among authors: lechevallier e. Cancer. 1995 Dec 15;76(12):2543-9. doi: 10.1002/1097-0142(19951215)76:12<2543::aid-cncr2820761221>3.0.co;2-s. Cancer. 1995. PMID: 8625083
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
Viens P, Gravis G, Bladou F, Lechevallier E, Baume D, Camerlo J, Cowen D, Coulange C, Serment G, Resbeut M, Maraninchi D. Viens P, et al. Among authors: lechevallier e. Eur Cytokine Netw. 1996 Sep;7(3):395-9. Eur Cytokine Netw. 1996. PMID: 8954183 Clinical Trial.
Prostate cancer in renal transplant recipients.
Lechevallier E, Cormier L, Barrou B, Benoit G, Bensadoun H, Boudjema K, Descottes JL, Doré B, Guy L, Malavaud B, Martin X, Petit J, Salomon L. Lechevallier E, et al. Transplant Proc. 2002 Mar;34(2):722. doi: 10.1016/s0041-1345(02)02624-6. Transplant Proc. 2002. PMID: 12009678 No abstract available.
Diagnosis and treatment of prostate cancers in renal-transplant recipients.
Cormier L, Lechevallier E, Barrou B, Benoit G, Bensadoun H, Boudjema K, Descottes JL, Doré B, Guy L, Malavaud B, Martin X, Patard JJ, Petit J, Salomon L. Cormier L, et al. Among authors: lechevallier e. Transplantation. 2003 Jan 27;75(2):237-9. doi: 10.1097/01.TP.0000041785.38998.6C. Transplantation. 2003. PMID: 12548131
[Urinary stones in subjects over the age of sixty].
Neuzillet Y, Lechevallier E, Ballanger P, Ferriere JM, Saussine C, Doré B, Conort P. Neuzillet Y, et al. Among authors: lechevallier e. Prog Urol. 2004 Sep;14(4):479-84. Prog Urol. 2004. PMID: 15776895 French.
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.
Verhoest G, Veillard D, Guillé F, De La Taille A, Salomon L, Abbou CC, Valéri A, Lechevallier E, Descotes JL, Lang H, Jacqmin D, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Mejean A, Patard JJ. Verhoest G, et al. Among authors: lechevallier e. Eur Urol. 2007 May;51(5):1298-304; discussion 1304-5. doi: 10.1016/j.eururo.2006.11.056. Epub 2006 Dec 8. Eur Urol. 2007. PMID: 17174023
318 results